Analytical tools applied to the characterization of drug - cyclodextrin inclusion complexes;Ferramentas analíticas aplicadas à caracterizaçã o de complexos de inclusão fármaco-ciclodextrina

Revista de Ciencias Farmaceuticas Basica e Aplicada

Volumn 31, Issue 2, 2010, Pages 117-124

  Lyra, M A M ^a   Alves, L D S ^a   Fontes, D A F ^a   Soares Sobrinho, J L ^a,b   Rolim Neto, Pedro José ^a  

^a FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^b FEDERAL UNIVERSITY OF PIAUÍ   (Brazil)

Author keywords

Analytical methods; Cyclodextrins; Inclusion complex; Spectroscopy

Indexed keywords

CYCLODEXTRIN;

ARTICLE; DISSOLUTION; FLUORESCENCE ANALYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INFRARED SPECTROSCOPY; ISOTHERMAL TITRATION CALORIMETRY; LIGHT ABSORPTION; LIQUID; NUCLEAR MAGNETIC RESONANCE; RAMAN SPECTROMETRY; SCANNING ELECTRON MICROSCOPY; SOLID STATE; THERMAL ANALYSIS; X RAY CRYSTALLOGRAPHY;

EID: 78649804673     PISSN: 18084532     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Aaltonen J, Gordon KC, Strachan CJ, Rades T. Perspectives in the use of spectroscopy to characterize pharmaceutical solids. Int J Pharm. 2008;34:159-69.
2. Araújo MVG, Macedo FLO, Nascimento CC, Conegero LS, Barreto LS, Almeida LE, Costa NB JR, Gimenez LF. Characterization, phase solubility and molecular modeling of β-cyclodextrin/pyrimethamine inclusion complex. Spectrochim Acta 2009;72:165-70.
3. Bettinetti GP, Sorrenti M, Rossi S, Ferrari F, Mura P, Faucci MT. Assessment of solid-state interactions of naproxen with amorphous cyclodextrin derivatives by DSC. J Pharm Biomed Anal. 2002;30:1173-9.
4. Bosch ME, Sanchez AJR, Rojas FS, Ojeda CB Recent advances in analytical determination of thalidomide and its metabolites. J Pharm Biomed Anal. 2008;46(1):9-17.
5. Bouquet WI, Ceelen W, Fritzinger B, Pattyn P, Peeters M, Remon JP, Vervaet C. Paclitaxel/β-cyclodextrin complexes for hyperthermic peritoneal perfusion - Formulation and stability. Eur J Pharm Biopharm. 2007;66:391-7.
6. Britto MAFO, Nascimento-JR CS, Santos HF. Análise Estrutural de Ciclodextrinas: Um Estudo Comparativo entre Métodos Teóricos Clássicos e Quânticos. Quim Nova 2004; 27(6):882-8.
7. Budal RM. Estudos de formação de complexos de inclusão em ciclodextrinas. [Dissertação] Florianópolis: Faculdade de química, UFSC; 2003.
8. Cannavà C, Crupi V, Ficarra P, Guardo M, Majolino D, Stancanelli R, Venuti V. Physicochemical characterization of coumestrol/β-cyclodextrins inclusion complexes by UV - vis and FTIR-ATR spectroscopies. Vib Spectrosc. 2008;48:172-8.
9. Challa R, Ahuja A, Ali J, Kharl, RK. Cyclodextrins in drug delivery: an updated review, AAPS Pharm Sci Tech. 2005;6:329-57.
10. Crupi V, Ficarra R, Guardo M, Majolino D, Stancanelli R, Venuti V. UV - vis and FTIR - ATR spectroscopic techniques to study the inclusion complexes of genistein with β-cyclodextrins. J Pharm Biomed Anal. 2007;44:110-7.
11. Cunha Filho MSS, Sá Barreto LCL. Utilização de ciclodextrinas na formação de complexos de inclusão de interesse farmacêutico. Rev Ciênc Farm Básica Apl. 2007;28 (1):1-9.
12. Duarte LC, Juchem PL, Pulz G M, Brum TMM, Chodur N, Liccardo A, Fischer AC, Acauan RB. Aplicações de Microscopia Eletrônica de Varredura (MEV) e Sistema de Energia Dispersiva (EDS) no Estudo de Gemas: exemplos brasileiros. Pesqui Geociênc. 2003;30(2):3-15.
13. Figueiras A, Carvalho RA, Ribeiro L, Torres-Labandeira JJ, Veiga FJB. Solid-state characterization and dissolution profiles of the inclusion complexes of omeprazole with native and chemically modified β-cyclodextrin. Eur J Pharm Biopharm. 2007a;67:531-9.
14. Figueiras A, Sarraguça JMG, Carvalho RA, Pais AACC, Veiga FJB. Interaction of omeprazole with a methylated derivative of β-cyclodextrin: phase solubility, NMR spectroscopy and molecular simulation, Pharm Res. 2007b;24(2):377-89.
15. Fraceto LF, Gonçalves MM, Moraes CM, Araújo DR, Zanella L, Paula E, Pertinhez TA. Caracterização do complexo de inclusão ropivacaína:β-ciclodextrina. Quím Nova 2007;30(5):1203-7.
16. Franco C, Schwingel L, Lula I, Sinisterra RD, Koester LS, Bassani VL. Studies on coumestrol/β-cyclodextrin association: Inclusion complex Characterization. Int J Pharm. 2009;369:5-11.
17. Górnas P, Neunert GZ, Ski KB, Polewski K. Beta-cyclodextrin complexes with chlorogenic and caffeic acids from coffee brew: Spectroscopic, thermodynamic and molecular modelling study. Food Chem. 2009;114:190-6.
18. Grillo R, Melo NFS, Moraes CM, Lima R, Menezes CMS, Ferreira EI, Rosa AH, Fraceto LF. Study of the interaction between hydroxymethylnitrofurazone and 2-hydroxypropyl-β-cyclodextrin. J Pharm Biomed Anal. 2008a;47:295-302.
19. Grillo R, Melo NFS, Fraceto LF, Brito CL, Trossini GHG, Menezes CMS, Ferreira EI, Moraes CM. Caracterização físico-química de complexo de inclusão entre hidroximetilnitrofurazona e hidroxipropil-β-ciclodextrina. Quím Nova 2008b;31(2): 290-5.
20. Guedes FL, Alves GMC, Santos FLA, Lima LF, Rolim LA, Rolim Neto PJ. Ciclodextrinas: como adjuvante tecnológico para melhorar a biodisponibilidade de fármacos. Rev Bras Farm. 2008;89(3):220-5.
21. Higuchi T, Connors KA. Phase-solubility techniques. In: Reilly CN. editor. Advances in analytical chemistry and instrumentation. New York, NY: Wiley-Interscience; 1965. p.117-212.
22. Jun SW, Min S, Kim MS, Kim JS, Park HJ, Lee S, Woo JS, Hwang JS. Preparation and characterization of simvastatin/hydroxypropyl-β- cyclodextrin inclusion complex using supercritical antisolvent (SAS) process. Eur J Pharm Biopharm. 2007;66:413-21.
23. Leal AAX, Henriques CA, Luna AS. Validação e estimativa da incerteza do método de determinação de fósforo por Espectrofotometria Uv-Vis. Rev Anal. 2008;32:28-34.
24. Li S, Purdy WC. Cyciodextrins and Their Applications in Analytical Chemistry. Chem Rev. 1992;92:1457-70.
25. Lima AN, Sobrinho JLS, Corrêa JR RAC, Rolim Neto PJ. Alternative Technologies to Improve Solubility of Poorly Water Soluble Drugs. Lat Am J Pharm. 2008;27(5):789-97.
26. Lu Y, Zhang X, Lai J, Yin Z, Wu W. Physical characterization of meloxicam- β -cyclodextrin inclusion complex pellets prepared by a fluid-bed coating method. Particuology 2009;7:1-8.
27. Marcelo G, Francisco R, Gonzalés-Álvarez MJ, Mendicuti F. Fluorescence properties of (R)- and (S)-[1,1-binaphthalene]-2,2-diols solutions and their complexes with cyclodextrins in aqueous medium. J Photochem Photobiol A Chem. 2008;200:114-25.
28. Melo FSN, Grillo R, Rosa AH. Interaction between nitroheterocyclic compounds with β - cyclodextrins: Phase solubility and HPLC studies. J Pharm Biomed Anal. 2008;47: 865-9.
29. Miller LA, Carrier RL, Ahmed I. Practical Considerations in Development of Solid Dosage Forms that Contain Cyclodextrin. J Pharm Sci. 2007;96:1691-707.
30. Misiuk W, Zalewska M. Investigation of inclusion complex of trazodone hydrochloride with hydroxypropyl-b-cyclodextrin, Carbohydr Polym. 2009;77(3):482-8.
31. Patel RP, Patel DJ, Bhimani DB, Patel JK. Physicochemical Characterization and Dissolution Study of Solid Dispersions of Furosemide with Polyethylene Glycol 6000 and Polyvinylpyrrolidone K30. Dissolut Technol. 2008;17-25.
32. Pralhad T, Rajendrakuma K. Study of freeze-dried quercetin-cycloextrin binary systems by DSC, FT-IR, X-ray diffractions and SEM analysis. J Pharm Biomed Anal. 2004;34: 333-9.
33. Rama ACR, Veiga F, Figueiredo IV, Sousa A, Caramona M. Complexos de inclusão de indometacina com hidroxipropil-β-ciclodextrina. Estudos de dissolução e coeficiente de partição. Rev Bras Cienc Farm. 2006;42(1):59-68.
34. Ribeiro A, Figueiras A, Santos D, Veiga F. Preparation and Solid-State Characterization of Inclusion Complexes Formed Between Miconazole and Methyl-β-Cyclodextrin. AAPS Pharm Sci Tech. 2008;9(4):1102-9.
35. Ribeiro L, Loftsson T, Ferreira D, Veiga F. Investigation and physicochemical characterization of vinpocetine-sulfobutyl ether β - cyclodextrin binary and ternary complexes. Chem Pharm Bull. 2003;51:914-22.
36. Rocha FRP, Teixeira LSG. Estratégias para aumento de sensibilidade em espectrofotometria UV-VIS. Quím Nova 2004;27(5):807-12.
37. Rossi B, Verrocchio P, Viliani G, Scarduelli G, Guella G, Mancini I. Vibrational properties of inclusion complex: the case of indomethacin- cyclodextrin. J Chem Phys. 2006;125(4):1-8.
38. Sá-Barreto LCL, Cunha-Filho MSS. Ciclodextrina: Importante Excipiente Farmacêutico Funcional. Lat Am J Pharm. 2008;27(4):629-36.
39. Shafi AAA, Shihry SS. Fluorescence enhancement of 1-napthol-5-sulfonate by forming inclusion complex with β-cyclodextrin in aqueous solution. Spectrochim Acta 2009;72: 533-7.
40. Sousa FB, Denadai AML, Lula IS, Lopes JFH, Elio FSHF, Almeida WB, Sinisterra RB. Supramolecular complex of fluoxetine with β - cyclodextrin: An experimental and theoretical study. Int J Pharm. 2008;353:160-9.
41. Soares-Sobrinho JL, Cunha-Filho MSS, Rolim-Neto PJ, Torres-Labandeira JJ, Dacunha-Marinho B. Benznidazole. Acta Crystallogr. 2008;64:634.
42. Spamer E, Muller DG, Wessels PL, Venter JP. Characterization of the complexes of furosemide with 2-hydroxypropyl-β-cyclodextrin and sulfobutyl ether-7-β-cyclodextrin. Eur J Pharm Biopharm. 2002;16:247-53.
43. Spricigo R, Botelho KCA, Consiglieri VO, Serra CHR. Obtenção e Avaliação de Complexos de Inclusão de Furosemida com β-ciclodextrina e hidroxipropil-β-ciclodextrina: Efeitos sobre as Propriedades de Dissolução do Fármaco. Lat Am J Pharm. 2008;27(5):645-53.
44. Stella VJ, Rajewski RA. Cyclodextrins: Their future in drug formulation and delivery. Pharm Res. 1997;14:556-67.
45. Uekama K, Hirayama F, Irie T. Cyclodextrin Drug Carrier Systems. Chem Rev. 1998; 98:2045-76.
46. Valle EMM. Cyclodextrins and their uses: a review. Process Biochem. 2004;39:1033-46.
47. Veiga FJB, Pecorelli CCMF, Ribeiro SSL. As ciclodextrinas em tecnologia farmacêutica. Coimbra: Editora Minerva Coimbra; 2006. p.140-3.
48. Venturine CG, Nicoline J, Machado C, Machado VG. Propriedades e aplicações recentes das ciclodextrinas. Quim Nova 2008;31(2):360-8.
49. Vueba ML, Pina ME, Veiga F, Sousa JJ, Batista CLAE. Conformational study of ketoprofen by combined DFT calculations and Raman spectroscopy. Int J Pharm. 2006; 307:56-65.
50. Zhang M, Li J, Zhang L, Chao J. Preparation and spectral investigation of inclusion complex of caffeic acid with hydroxypropyl-cyclodextrin. Spectrochim Acta 2009;71: 1891-5.